Antibody arrays in biomarker discovery

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Life's processes are governed by chemical reactions; disruptions lead to diseases like cancer, autoimmunity, and infections.
• Specific molecules (cytokines, chemokines, growth factors) are altered in disease, serving as potential biomarkers.
• Single biomarkers are often insufficient; a comprehensive approach is needed for accurate disease understanding.

Purpose of the Study:

• To discuss the evolution and applications of antibody arrays in biomarker discovery.
• To highlight the role of antibody arrays in drug target identification and disease detection.
• To showcase the broad utility of antibody arrays across various medical fields.

Main Methods:

• Utilizes antibody arrays for high-throughput, multiplexed chemical detection.
• Analyzes alterations in various chemical moieties (biomolecules) in disease states.
• Leverages established biomarker examples like carcinoembryonic antigen and prostate-specific antigen.

Main Results:

• Antibody arrays provide a global perspective for disease biomarker discovery.
• This technology facilitates high-throughput detection of numerous disease markers.
• Demonstrates successful application in identifying drug targets and therapeutic markers.

Conclusions:

• Antibody arrays are essential for comprehensive disease biomarker discovery.
• They enable earlier disease detection and improved prognostic indicators.
• The technology holds significant promise for diverse conditions including asthma, renal disease, and neurological disorders.